Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy

NCT03499912 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03499912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03499912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 29, 2017
Completion date
July 1, 2019
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia